Displaying 2181 - 2200 of 2441
FTC Reaches Record Financial Settlement To Settle Charges of Price-fixing in Generic Drug Market
Mylan Laboratories, Inc., Cambrex Corporation, Profarmaco S.R.I., and Gyma Laboratories of America, Inc.
Complaint filed in the U.S. District Court for the District of Columbia charged Mylan with restraint of trade, monopolization and conspiracy to monopolize the market for two generic drugs used to treat anxiety, lorazepam and clorazepate, through exclusive dealing arrangements. The Commission alleged that Mylan, Gyma Laboratories of America, Inc., Cambrex Corporation and Profarmaco S.R.L. conspired to deny Mylan’s competitors ingredients necessary to manufacture lorazepam and 40 clorazepate. The complaint sought consumer redress of at least $120 million and to enjoin the alleged illegal exclusive licensing agreements. The district court upheld the Commission’s authority to seek restitution in antitrust injunction actions under Section 13(b). The Commission approved a $100 million settlement. The opinion settled Commission concerns that Mylan, Gyma Laboratories of America, Inc., Cambrex Corporation and Profarmaco S.R.L. conspired to deny Mylan’s competitors ingredients necessary to manufacture lorazepam and 40 clorazepate. On February 1, 2002, the court granted approval to a plan of distribution to injured consumers who paid the increased prices and state agencies, including Medicaid programs, that purchased the drugs while the illegal agreements were in effect. The funds were distributed by the states.
Antitrust Economics: Three Cheers and Two Challenges
EU and U.S. Approaches to International Mergers--Views from the U.S. Federal Trade Commission
Workshop on Competition Policy in the World of B2B Electronic Marketplaces
Workshop on Slotting Allowances and Other Grocery Marketing Practices
"The Nature and Limits of Restructuring in Merger Review"
FTC Preserves Competition in Market for Title Information Services
Abuse of Dominance in Relation to Intellectual Property: U.S. Perspectives and the Intel Cases
Emerging Antitrust Issues in Electronic Commerce
What Are We Learning from the Microsoft Case?
Announced Actions for September 16, 1999
Workshop: Market Power and Consumer Protection Issues Involved with Encouraging Competition in the U.S. Electric Industry
FTC Releases Report on Commission's Divestiture Process
Displaying 2181 - 2200 of 2441